Find Pharmaceutical Peptides , Pharmaceutical Intermediate, Amino Acid on Industry Directory, Reliable Manufacturer/Supplier/Factory from China.

Inquiry Basket (0)
Home > Products > Pharmaceutical Peptides > Pharmaceutical Peptides Bivalirudin Acetate /Bivalirudin Trifluoroacetate /128270-60-0

Pharmaceutical Peptides Bivalirudin Acetate /Bivalirudin Trifluoroacetate /128270-60-0

Basic Info

Model No.:  API

Product Description

Model NO.: API Customized: Customized Suitable for: Adult Purity: >98% Mf: C98h138n24o33 Appearance: White Powder Type: Pharmaceutical Intermediates Shelf Life: 2 Years Transport Package: Box Origin: Shanghai Powder: Yes Certification: GMP, HSE, ISO 9001, USP, BP State: Solid CAS No: 128270-60-0 Other Names: Bivalirudin Trifluoroacetate Place of Origin: Shang Hai China (Mainland) The Purity: Over 98% Shipping Method: FedEx, DHL, EMS or by Air Specification: g                     Pharmaceutical Peptides Bivalirudin Acetate /Bivalirudin Trifluoroacetate /128270-60-0
Quick Details
CAS No.: 128270-60-0 Other Names: Bivalirudin MF: C98H138N24O33
EINECS No.: 128270-60-0 Type: Agrochemical Intermediates, Dyestuff Intermediates, Flavor & Fragrance Intermediates, Pharmaceutical Intermediates, Syntheses Material Intermediates, Anesthetic Agents Purity: 99%
Brand Name: Richest Model Number: 99% Place of Origin: Shanghai China (Mainland)
Grade Standard: Medicine Grade color: white

Description    
roduct Name Bivalirudin Acetate 
Cas No. 128270-60-0
Molecular Formula C98H138N24O33
Molecular Weight 2180.33
Purity (HPLC) 99.0%min.
Appearance  White powder
Single Impurity (HPLC)  0.5%max
Amino Acid Composition  ±10% of theoretical
Peptide Content (N%) ≥80.0%
Water Content (Karl Fischer)  ≤8.0%
Acetate Content (HPIC) ≤12.0%
MS (ESI) Consistent
Mass Balance  95.0~105.0%
Introduction :
Bivalirudin is a DTI that overcomes many limitations seen with indirect thrombin inhibitors, such as heparin. Bivalirudin is a short, synthetic peptide that is potent, highly specific, and a reversible inhibitor of thrombin.It inhibits both circulating and clot-bound thrombin,while also inhibiting thrombin-mediated platelet activation and aggregation. Bivalirudin has a quick onset of action and a short half-life.It does not bind to plasma proteins (other than thrombin) or to red blood cells. Therefore it has a predictable antithrombotic response. There is no risk for Heparin Induced Thrombocytopenia/Heparin Induced Thrombosis-Thrombocytopenia Syndrome (HIT/HITTS).It does not require a binding cofactor such as antithrombin and does not activate platelets.These characteristics make bivalirudin an ideal alternative to heparin.

Contact us if you need more details on Peptides. We are ready to answer your questions on packaging, logistics, certification or any other aspects about Pharmaceutical IntermediateAmino Acid. If these products fail to match your need, please contact us and we would like to provide relevant information.

Product Categories : Pharmaceutical Peptides